Delivery Order SPE2DR25D2108-SPE2DR26F6ST7
- Not listed
- The Defense Logistics Agency awarded a $37,798.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lotrel 10-20 mg capsules (100-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,324.10 to AmerisourceBergen Drug Corp for the supply of Lotrel 10-40 mg capsules (100 count). This competitive, firm fixed-price delivery order was awarded on December 19, 2025, with an ultimate completion date of December 22, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide LOTREL 10-20 mg capsules. The $3,721.09 contract has a period of performance through March 18, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. AmerisourceBergen Drug Corp also holds a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $81,406.88 worth of LOTREL 10-20 MG CAPSULE 100S. This delivery order falls under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lotrel 10-20 mg capsules. The $31,616.33 firm fixed price contract has an ultimate completion date of August 22, 2024. This order is part of a larger indefinite delivery contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,023.63 firm fixed-price delivery order is for the supply of 100 capsules of the medication Lotrel 5-10 mg. The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,174.18 firm fixed-price delivery order is for 4,561,028,460 units of the drug Lotrel (Amlodipine Besylate and Benazepril Hydrochloride) 10-20 mg capsules. The contract has a completion date of May 24, 2023 and was awarded on May 23, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $9,072.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lotrel 10-20 mg capsules to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $15,309.96 firm-fixed-price delivery order is for the supply of Lotrel 10-20 mg capsules to support military healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,749.29 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6ST7Delivery Order
The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp for $1,398.98 on February 3, 2026, for the supply of Lotrel 5-10 mg capsules (100-count units). This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. The delivery order is scheduled for ultimate completion on February 4, 2026, with fulfillment from the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this procurement, indicating full and open competition. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal supply chain, supporting military healthcare systems and other government medical institutions through its comprehensive product portfolio spanning brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Lotrel, a combination antihypertensive medication, exemplifies the company's ongoing role in fulfilling routine pharmaceutical needs for the Department of Defense healthcare enterprise. The parent company's large umbrella contract with DLA enables efficient ordering of diverse pharmaceutical commodities while maintaining predictable pricing and supply chain stability for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/2/26 |